Twenty patients with intestinal giardiasis, already resistant to 3-5 previous courses of oral metronidazole, were randomly distributed into 2 different groups: 10 subjects were given oral albendazole (440 mg/two times per day for 7 days) and 10 were submitted to the association of albendazole (400 mg/two times per day for 7 days) plus metronidazole (250 mg/three times per day for 7 days). All patients were evaluated both for clinical and parasitological status, immediately before and after therapy and, then, 4 weeks later. Only 3 patients of those treated with albendazole alone, showed a clinical and parasitological remission at the end of therapy, and one of them relapsed 4 weeks later. All patients who underwent albendazolemetronidazole association responded to the therapy and all except one were defined as "cured" 4 weeks later. Our study demonstrates that albendazole alone is not an effective therapeutic alternative for "metronidazole-resistant" giardiasis. The association of metronidazole plus albendazole seems synergic and deserves further studies.
|Titolo:||Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis|
|Data di pubblicazione:||1995|
|Citazione:||Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis / Cacopardo B; Patamia I; Bonaccorso V; Di Paola O; Bonforte S; Brancati G.. - 146:12(1995), pp. 761-767.|
|Appare nelle tipologie:||1.1 Articolo in rivista|